View Item 

Show simple item record

Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program
dc.contributor.authorKim, Catherineen_US
dc.contributor.authorBarrett‐connor, Elizabethen_US
dc.contributor.authorRandolph, John F.en_US
dc.contributor.authorKong, Shengchunen_US
dc.contributor.authorNan, Binen_US
dc.contributor.authorMather, Kieren J.en_US
dc.contributor.authorGolden, Sherita H.en_US
dc.date.accessioned2014-05-21T18:02:43Z
dc.date.available2015-06-01T15:48:44Zen_US
dc.date.issued2014-03en_US
dc.identifier.citationKim, Catherine; Barrett‐connor, Elizabeth ; Randolph, John F.; Kong, Shengchun; Nan, Bin; Mather, Kieren J.; Golden, Sherita H. (2014). "Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program." Obesity 22(3): 882-887.en_US
dc.identifier.issn1930-7381en_US
dc.identifier.issn1930-739Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106683
dc.publisherWiley Periodicals, Inc.en_US
dc.titleSex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention programen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelEndocrinologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106683/1/oby20527.pdf
dc.identifier.doi10.1002/oby.20527en_US
dc.identifier.sourceObesityen_US
dc.identifier.citedreferenceGambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight‐obese women with polycystic ovary syndrome: a randomized, 12‐month, placebo‐controlled study. J Clin Endocrinol Metab 2006; 91: 3970 ‐ 3980.en_US
dc.identifier.citedreferenceEvans E, Van Pelt R, Binder E, Williams D, Ehsani A, Kohrt W. Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women. J Appl Physiol 2001; 90: 2033 ‐ 2040.en_US
dc.identifier.citedreferenceO'Sullivan A, Crampton L, Freund J, Ho K. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998; 102: 1035 ‐ 1040.en_US
dc.identifier.citedreferencedos Reis C, de Melo N, Meirelles E, Vezozzo D, Halpern A. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal estrogen. Maturitas 2003; 46: 59 ‐ 68.en_US
dc.identifier.citedreferenceHanggi W, Lippuner K, Jaeger P, Birkhauser M, Horber F. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol (Oxf) 1998; 48: 691 ‐ 699.en_US
dc.identifier.citedreferenceKuller L, Kinzel L, Pettee K, et al. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial. J Womens Health (Larchmt) 2006; 15: 962 ‐ 974.en_US
dc.identifier.citedreferenceKnowler W, Barrett‐Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393 ‐ 403.en_US
dc.identifier.citedreferenceKim C, Nan B, Laughlin G, et al. Endogenous sex hormone changes in postmenopausal women in the Diabetes Prevention Program. J Clin Endocrinol Metab 2012; 97: 2853 ‐ 2861.en_US
dc.identifier.citedreferenceKim C, Kong S, Laughlin G, et al. Reductions in glucose among postmenopausalw omen who use and do not use estrogen therapy. Menopause 2012; epub, ahead of print.en_US
dc.identifier.citedreferenceSodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol‐17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801 ‐ 810.en_US
dc.identifier.citedreferenceWildman R, Tepper P, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012;epub ahead of print.en_US
dc.identifier.citedreferenceRairy C, Ratcliffe S, Weinstein R, et al. Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the Cardiovascular Health Study. J Clin Endocrinol Metab 2011; 96: 989 ‐ 996.en_US
dc.identifier.citedreferenceLiedtke S, Schmidt M, Vrieling A, et al. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012; 20: 1088 ‐ 1095.en_US
dc.identifier.citedreferenceMohamed‐Ali V, Pinckney J, Coppack S. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145 ‐ 1158.en_US
dc.identifier.citedreferenceBrowning J, Szczepaniak L, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387 ‐ 1395.en_US
dc.identifier.citedreferencePeter A, Kantartzis K, Machann J, et al. Relationship of circulating sex hormone‐binding globulin with metabolic traits in humans. Diabetes 2010; 59: 3167 ‐ 3173.en_US
dc.identifier.citedreferenceHaarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 41: 1323 ‐ 1326.en_US
dc.identifier.citedreferenceLovejoy J, Bray G, Bourgeois M, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women: a clinical research study. J Clin Endocrinol Metab 1996; 81: 2198 ‐ 2203.en_US
dc.identifier.citedreferenceToth M, Tchernof A, Sites C, Poehlman E. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 2000; 24: 226 ‐ 231.en_US
dc.identifier.citedreferenceNorman R, Flight I, Rees M. Oestrogen and progestogen hormone replacement therapy for perimenopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000; 2: CD1001018.en_US
dc.identifier.citedreferenceEspeland M, Stefanick M, Kritz‐Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen‐Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997; 82: 1549 ‐ 1556.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
oby20527.pdf
Size:
143.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.